Evidence map›Paper›PMID 39879326›Full record

ArticleAnalytical chemistry2025

Hyperspectral Imaging for High Throughput Optical Spectroscopy of pL Droplets.

Marc Sulliger, Jaime Ortega Arroyo, Romain Quidant

Abstract read
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Real-time optical spectroscopy forNanoscale advances · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marc SulligerNanophotonic Systems Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland.ORCID 0000-0002-2706-3912
Jaime Ortega ArroyoNanophotonic Systems Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland.ORCID 0000-0002-0657-051X
Romain QuidantNanophotonic Systems Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland.ORCID 0000-0001-8995-8976

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Droplet-based microfluidics is a powerful tool for high-throughput analysis of liquid samples with significant applications in biomedicine and biochemistry. Nevertheless, extracting content-rich information from single picolitre-sized droplets at high throughputs remains challenging due to the weak signals associated with these small volumes. Overcoming this limitation would be transformative for fields that rely on high-throughput screening, enabling broader multiparametric analysis. Here we present an integrated optofluidic platform that addresses this critical point by combining advanced hyperspectral imaging with self-referencing and measurement automation. With this approach our platform achieves high temporal and spectral resolution with shot-noise limited performance, allowing for the label-free interrogation of single droplet contents. To demonstrate the platform's capabilities, we first exploit its high temporal and spectral resolution to study rapid dynamic changes in the composition of a heterogeneous population of nanoparticles. Second, leveraging the platform's shot-noise limited performance and using a model DNA-AuNP sensor, we detect target DNA sequences down to 250 pM, thereby showcasing the platform's compatibility with demanding sensing applications. Finally, through measurement automation, we demonstrate multiplexed sample monitoring over hours. These findings show that our optofluidic platform not only helps to close the current gap in high-throughput droplet analysis, but also significantly advances the potential for content-rich characterization, ultimately enhancing the scope and effectiveness of high-throughput screening methods.

Indexed as

DNAHigh-Throughput Screening AssaysHyperspectral ImagingMicrofluidic Analytical TechniquesGoldMetal NanoparticlesDNAGold

Identifiers

PMID39879326
PMCPMC11822737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.